Evidence map›Paper›PMID 27069421›Full record

ArticleThe Cochrane database of systematic reviews2016

Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.

Lise J Estcourt, Patricia M Fortin, Sally Hopewell, Marialena Trivella

Abstract read
In one paragraph

Article in The Cochrane database of systematic reviews, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Interventions for chronic kidney disease in people with sickle cell disease.The Cochrane database of systematic reviews · 2023
    Pooled it
  2. Article
  3. Commonly used agent for acute pain management of sickle cell anemia in Saudi Emergency Department: A narrative review.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2021
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Lise J EstcourtHaematology/Transfusion Medicine, NHS Blood and Transplant, Oxford, UK.
Patricia M FortinSystematic Review Initiative, NHS Blood and Transplant, Oxford, UK.
Sally HopewellOxford Clinical Trials Research Unit, University of Oxford, Oxford, UK.
Marialena TrivellaCentre for Statistics in Medicine, University of Oxford, Oxford, UK.
John Radcliffe Hospital · GBNHS Blood and Transplant · GBNuffield Orthopaedic Centre · GBUniversity of Oxford · GB

Funding

Cancer Research UK 16895Department of Health 13/89/09Department of Health SRP/13/89/09
6 · The paper itself

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To summarize the evidence in Cochrane reviews of the effectiveness and safety of red cell transfusions versus no transfusion, or restrictive (to increase the total haemoglobin) versus liberal (to decrease the haemoglobin S level below a specified percentage) transfusion, for treatment or prevention of complications experienced by people with SCD.

Identifiers

PMID27069421
PMCPMC4826604
OpenAlexW2271926706

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.